How MARA Rating Company maintains, reviews, and updates ratings to preserve comparability and defensibility over time.

Purpose

MARA Rating Actions describe how ratings are affirmed, revised, or placed under review when material evidence or reimbursement conditions change.
The objective is to maintain a stable, comparable, and defensible market-access risk signal over time.

Rating Action Types

Surveillance Framework

MARA ratings are subject to:

  • Event-driven surveillance – triggered by material clinical, economic, or policy developments.

  • Periodic review – conducted at least annually to ensure continued alignment with evidence and HTA context.

Material Event Triggers (Non-Exhaustive)

  • New pivotal clinical data

  • New HTA decisions or payer policy updates

  • Label expansions or restrictions

  • Material pricing or reimbursement developments

  • Significant safety findings

  • Major changes in standard of care

  • Documented methodological corrections

Process & Governance Controls

  • Ratings are determined through structured committee judgment.

  • No single analyst determines outcomes.

  • Evidence is restricted to public, verifiable sources.

  • Committee minutes are recorded.

  • Issuers may correct factual errors but cannot direct rating outcomes.